Atopic Dermatitis Treatment Equally Effective in Extrinsic, Intrinsic Subtypes

Patients who have extrinsic (EAD) or intrinsic atopic dermatitis (IAD) serve to benefit equally from dupilumab, even when considering immunoglobulin E levels, which are elevated in EAD but remain normal in IAD.

Related Keywords

Italy , ,Dermatology Clinic Of The Turin University Hospital ,Dermatology Clinic ,Turin University Hospital ,Severity Index ,Dermatology Life Quality Index ,Intrinsic Atopic Dermatitis ,Extrinsic Atopic Dermatitis ,Immunoglobulin E ,Areasi ,Cdlqi ,